Literature DB >> 19801545

A human germ line antibody light chain with hydrolytic properties associated with multimerization status.

Vikram Sharma1, William Heriot, Kirk Trisler, Vaughn Smider.   

Abstract

Antibodies with nucleophilic or catalytic properties often have these characteristics encoded in their germ line genes. Because hydrolytic activity has been reported to be associated with light chain V regions, we have begun an analysis of germ line light chain proteins that could be the basis for affinity maturation into hydrolytic or other reactive antibodies. We produced the germ line A18b light chain and characterized its hydrolytic, nucleophilic, and tertiary structural activities. This light chain was purified to >99% purity and found to hydrolyze aminomethylcoumarin-peptide and larger protein substrates and bind a fluorophosphonate probe. Mutation of putative catalytic residues only resulted in loss of activity of a tetrameric but not dimeric form of the light chain. These biochemical properties provide a framework for understanding the structure-function relationships of germ line antibodies.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19801545      PMCID: PMC2785149          DOI: 10.1074/jbc.M109.036087

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  37 in total

1.  Activity-based protein profiling: the serine hydrolases.

Authors:  Y Liu; M P Patricelli; B F Cravatt
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-21       Impact factor: 11.205

2.  High levels of catalytic antibodies correlate with favorable outcome in sepsis.

Authors:  Sébastien Lacroix-Desmazes; Jagadeesh Bayry; Srini V Kaveri; David Hayon-Sonsino; Nithyananda Thorenoor; Julien Charpentier; Charles-Edouard Luyt; Jean-Paul Mira; Valakunja Nagaraja; Michel D Kazatchkine; Jean-François Dhainaut; Vincent O Mallet
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-02       Impact factor: 11.205

3.  Super catalytic antibody [I]: decomposition of targeted protein by its antibody light chain.

Authors:  E Hifumi; Y Okamoto; T Uda
Journal:  J Biosci Bioeng       Date:  1999       Impact factor: 2.894

Review 4.  Pathophysiology of catalytic antibodies.

Authors:  Sébastien Lacroix-Desmazes; Bharath Wootla; Sandrine Delignat; Suryasarathi Dasgupta; Valakunja Nagaraja; Michel D Kazatchkine; Srini V Kaveri
Journal:  Immunol Lett       Date:  2005-11-02       Impact factor: 3.685

5.  Structural insights into the evolution of an antibody combining site.

Authors:  G J Wedemayer; P A Patten; L H Wang; P G Schultz; R C Stevens
Journal:  Science       Date:  1997-06-13       Impact factor: 47.728

6.  Stepwise intraclonal maturation of antibody affinity through somatic hypermutation.

Authors:  C Kocks; K Rajewsky
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

Review 7.  Catalytic antibodies in healthy humans and patients with autoimmune and viral diseases.

Authors:  G A Nevinsky; Valentina N Buneva
Journal:  J Cell Mol Med       Date:  2003 Jul-Sep       Impact factor: 5.310

8.  Site-directed mutagenesis of proteolytic antibody light chain.

Authors:  Q S Gao; M Sun; A R Rees; S Paul
Journal:  J Mol Biol       Date:  1995-11-10       Impact factor: 5.469

9.  Routes to covalent catalysis by reactive selection for nascent protein nucleophiles.

Authors:  Andrey V Reshetnyak; Maria Francesca Armentano; Natalia A Ponomarenko; Domenica Vizzuso; Oxana M Durova; Rustam Ziganshin; Marina Serebryakova; Vadim Govorun; Gennady Gololobov; Herbert C Morse; Alain Friboulet; Sudesh P Makker; Alexander G Gabibov; Alfonso Tramontano
Journal:  J Am Chem Soc       Date:  2007-11-29       Impact factor: 15.419

10.  Antibody engineering for the analysis of affinity maturation of an anti-hapten response.

Authors:  D Allen; T Simon; F Sablitzky; K Rajewsky; A Cumano
Journal:  EMBO J       Date:  1988-07       Impact factor: 11.598

View more
  4 in total

1.  Constant domain-regulated antibody catalysis.

Authors:  Gopal Sapparapu; Stephanie Planque; Yukie Mitsuda; Gary McLean; Yasuhiro Nishiyama; Sudhir Paul
Journal:  J Biol Chem       Date:  2012-09-04       Impact factor: 5.157

2.  IgG Fab fragments forming bivalent complexes by a conformational mechanism that is reversible by osmolytes.

Authors:  Alfreda D Nelson; Michele M Hoffmann; Christopher A Parks; Surendra Dasari; Adam G Schrum; Diana Gil
Journal:  J Biol Chem       Date:  2012-10-29       Impact factor: 5.157

3.  Physiological IgM class catalytic antibodies selective for transthyretin amyloid.

Authors:  Stephanie A Planque; Yasuhiro Nishiyama; Mariko Hara; Sari Sonoda; Sarah K Murphy; Kenji Watanabe; Yukie Mitsuda; Eric L Brown; Richard J Massey; Stanley R Primmer; Brian O'Nuallain; Sudhir Paul
Journal:  J Biol Chem       Date:  2014-03-19       Impact factor: 5.157

4.  CD4 binding determinant mimicry for HIV vaccine design.

Authors:  Yasuhiro Nishiyama; Stephanie Planque; Carl V Hanson; Richard J Massey; Sudhir Paul
Journal:  Front Immunol       Date:  2012-12-17       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.